Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Mechanisms of Rare Disorder May Shed Light on Parkinson’s Disease
Disease Discoveries

Mechanisms of Rare Disorder May Shed Light on Parkinson’s Disease

By Nora DunneDec 17, 2014
Share
Facebook Twitter Email
Electronic microscopy images of wild-type (left) and PARK9-mutant (right) cells reveals that a decreased number of vesicles transport α-synuclein out of mutant neurons. 

 

By studying a genetic mutation in patients with a rare Parkinson’s-like disorder, Northwestern Medicine scientists are working to to understand the mechanisms behind the more common form of the disease.

In a recent study, Dimitri Krainc, MD, PhD, Aaron Montgomery Ward Professor and chair of the Ken and Ruth Davee Department of Neurology, and Taiji Tsunemi, MD, PhD, research assistant professor in Neurology, studied a mutation in the PARK9 gene, which is found in patients with Kufor-Rakeb syndrome. The disorder is characterized by juvenile-onset symptoms similar to Parkinson’s disease, including movement abnormalities and dementia.

Drs. Krainc and Tsunemi explored how the PARK9 mutation contributes to abnormal accumulation of α-synuclein, a protein that facilitates communication between neurons.

The answer involved cellular recycling factories in the brain called lysosomes, which are organelles responsible for removing cell debris. When they malfunction, α-synuclein builds up in cells instead of being properly disposed, contributing to neurodegeneration and symptoms of parkinsonism.

Dimitri Krainc, MD, chair of the Ken and Ruth Davee Department of Neurology, discovered that lysosomal function is abnormal in patients with a rare form of parkinsonism, a finding that may apply to more common Parkinson’s disease.

“We found that lysosomes do not work properly in patients with PARK9 mutation, suggesting that PARK9 plays a role on normal function of lysosomes,” Dr. Krainc said.

The scientists also found that the PARK9 mutation also impairs exosomes, cellular vesicles that release α-synuclein from one cell to those cells neighboring it.

Patients with Kufor-Rakeb syndrome respond well to the same symptomatic drug treatment that patients with Parkinson’s disease take. This all implies that the underlying mechanisms of both conditions are similar.

“We study this rare disease because we know the specific gene that is abnormal,” said Dr. Krainc, who is also director of the Center for Rare Neurological Diseases. “Clear disease mechanisms and targets for the rare genetic disorders provide a window that can help us establish a platform to develop new drugs for both the rare and common disorders.”

The findings of this study, published in the Journal of Neuroscience, could apply to more frequent forms of Parkinson’s disease that don’t have a clear genetic root.

The scientists are currently investigating whether lysosomal function is also abnormal in patients with Parkinson’s disease, to see if their findings about the rare disease correlate to more common forms.

“If that’s the case, we can try to upregulate the activity of this gene and the protein, to improve the recycling capacity of neurons so they can digest accumulated debris in much more efficient way,” Dr. Krainc said.

This work was supported by National Institutes of Health (NIH) grant R01NS076054.

Neurology and Neuroscience Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Comments are closed.

Latest News

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
pride7
pride6
pride5
pride4
pride3
pride2
pride1
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.